Jacobson Mark L.
SEC insider (Form 3/4/5 filer). CIK 0001805812. Chief Operating Officer at Axsome Therapeutics, Inc. (AXSM). 25 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in NEW YORK, NY.
Companies Jacobson Mark L. has filed insider reports for
- Axsome Therapeutics, Inc. (AXSM): Officer, Chief Operating Officer
Jacobson Mark L.
CIK: 0001805812
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Axsome Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Sep 3, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect10K shares at avg. $208.65$2.1M - Sep 3, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect10K shares at avg. $12.95$130K - May 5, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect233 shares at avg. $228.18$53K - May 5, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect233 shares at avg. $12.95$3K - May 4, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect4.5K shares at avg. $12.95$58K - May 4, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect4.5K shares at avg. $227.94$1.0M - Apr 21, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectPerformance Stock Units
8.7K shares- - Feb 26, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
19.7K shares- - Feb 26, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect35.4K shares at avg. $2.85$101K - Feb 26, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect35.4K shares at avg. $161.88$5.7M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 10,000 | $208.65 | $2,086,500 | Direct |
| Sep 3, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 10,000 | $12.95 | $129,500 | Direct |
| May 5, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 233 | $228.18 | $53,166 | Direct |
| May 5, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 233 | $12.95 | $3,017 | Direct |
| May 4, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 4,517 | $12.95 | $58,495 | Direct |
| May 4, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 4,517 | $227.94 | $1,029,605 | Direct |
| Apr 21, 2026 | AXSM Axsome Therapeutics, Inc. | Award Performance Stock Units | 8,669 | - | - | Direct |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 19,663 | - | - | Direct |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 35,378 | $2.85 | $100,827 | Direct |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 35,378 | $161.88 | $5,726,991 | Direct |
1-10 of 25 transactions